These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24285629)

  • 1. Understanding the investigators: a qualitative study investigating the barriers and enablers to the implementation of local investigator-initiated clinical trials in Ethiopia.
    Franzen SR; Chandler C; Enquselassie F; Siribaddana S; Atashili J; Angus B; Lang T
    BMJ Open; 2013 Nov; 3(11):e003616. PubMed ID: 24285629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka.
    Franzen SRP; Chandler C; Siribaddana S; Atashili J; Angus B; Lang T
    BMJ Open; 2017 Oct; 7(10):e017246. PubMed ID: 29030412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of country-level enablers, barriers and recommendations to strengthen institutional capacity for evidence uptake in decision-making.
    Schleiff MJ; Kuan A; Ghaffar A
    Health Res Policy Syst; 2020 Jul; 18(1):78. PubMed ID: 32646439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and opportunities of translating animal research into human trials in Ethiopia.
    Abrhaley A; Giday M; Hailu A
    BMC Med Res Methodol; 2024 Sep; 24(1):211. PubMed ID: 39300349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia.
    Belay S; Giday M; Manyazewal T
    Front Public Health; 2021; 9():621433. PubMed ID: 33869126
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigator barriers and preferences to conduct clinical drug trials in Finland: a qualitative study.
    Keinonen T; Keränen T; Klaukka T; Saano V; Ylitalo P; Enlund H
    Pharm World Sci; 2003 Dec; 25(6):251-9. PubMed ID: 14689812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thematic analysis of the role of the organisation in building allied health research capacity: a senior managers' perspective.
    Golenko X; Pager S; Holden L
    BMC Health Serv Res; 2012 Aug; 12():276. PubMed ID: 22920443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to knowledge translation activities within academic institutions in low- and middle-income countries.
    Kalbarczyk A; Rodriguez DC; Mahendradhata Y; Sarker M; Seme A; Majumdar P; Akinyemi OO; Kayembe P; Alonge OO
    Health Policy Plan; 2021 Jun; 36(5):728-739. PubMed ID: 33661285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information sharing across institutions: Practices and barriers during public health emergencies in Ethiopia.
    Sasie SD; Van Zuylen P; Ayano G; Aragaw FM; Spigt M
    Int J Med Inform; 2024 Jun; 186():105439. PubMed ID: 38564958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability and barriers to implementation of N-of-1 tests in Ethiopia - a qualitative study.
    Alemayehu C; Mitchell G; Nikles J; Aseffa A; Clavarino A
    BMC Med Res Methodol; 2019 Oct; 19(1):192. PubMed ID: 31615422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited capacity in US pediatric drug trials: qualitative analysis of expert interviews.
    Wasserman R; Bocian A; Harris D; Slora E
    Paediatr Drugs; 2011 Apr; 13(2):119-24. PubMed ID: 21351811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practices and Attitudes of Swiss Stakeholders Regarding Investigator-Initiated Clinical Trial Funding Acquisition and Cost Management.
    McLennan S; Griessbach A; Briel M;
    JAMA Netw Open; 2021 Jun; 4(6):e2111847. PubMed ID: 34076698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "We do not know how to screen and provide treatment": a qualitative study of barriers and enablers of implementing perinatal depression health services in Ethiopia.
    Dadi AF; Miller ER; Azale T; Mwanri L
    Int J Ment Health Syst; 2021 May; 15(1):41. PubMed ID: 33952338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and enablers to the delivery of psychological care in the management of patients with type 2 diabetes mellitus in China: a qualitative study using the theoretical domains framework.
    Chapman A; Yang H; Thomas SA; Searle K; Browning C
    BMC Health Serv Res; 2016 Mar; 16():106. PubMed ID: 27025727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of Research Quality and Knowledge Transfer and Translation and Capacity Strengthening Strategies for Sound Health Policy Decision-Making in Palestine.
    AlKhaldi M; Meghari H; Jillson IA; Alkaiyat A; Tanner M
    Int J Public Health; 2021; 66():620425. PubMed ID: 34408619
    [No Abstract]   [Full Text] [Related]  

  • 19. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.